论文部分内容阅读
选取我院2013年7月至2015年7月外科住院的2型糖尿病患者46例,经我科会诊后,根据患者的血糖控制水平,个体化应用胰岛素泵控制血糖,观察治疗效果。结果 46例外科住院的2型糖尿病患者个体化接受胰岛素泵治疗(3.87±2.10)d后,餐前血糖、餐后2h血糖明显降低,与治疗前比较差异有统计学意义(P<0.05),围手术期未出现低血糖、黎明现象及切口感染等并发症。结论在2型糖尿病患者围手术期个体化应用胰岛素泵能确保患者手术顺利完成,无糖尿病相关的并发症发生,因而缩短了住院时间,提高了临床疾病治疗的有效性及安全性,具有良好的临床应用疗效。
Forty-six patients with type 2 diabetes admitted to our hospital from July 2013 to July 2015 were enrolled in this study. After consultation with our department, the blood glucose level was controlled according to the level of blood glucose control and the insulin pump was used to control the blood glucose level. Results 46 patients with type 2 diabetes mellitus hospitalized with insulin pump (3.87 ± 2.10) d had a significant decrease in postprandial blood glucose and 2h postprandial blood glucose, which was significantly different from those before treatment (P <0.05) No perioperative hypoglycemia, dawn phenomenon and incision infection and other complications. Conclusion The perioperative application of insulin pump in patients with type 2 diabetes mellitus can ensure the successful completion of surgery without complications related to diabetes, thus shortening the length of hospital stay and improving the effectiveness and safety of clinical treatment, with good Clinical application of curative effect.